WordNet
- any of several drugs that control or kill neoplastic cells; used in chemotherapy to kill cancer cells; all have unpleasant side effects that may include nausea and vomiting and hair loss and suppression of bone marrow function (同)antineoplastic_drug, cancer drug
- an antineoplastic drug that inhibits the utilization of a metabolite
PrepTutorEJDIC
- 腫瘍(しゅよう)の成長を防止する
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. ブドウ膜炎：治療 uveitis treatment
- 2. 肝疾患を有する患者における化学療法による肝毒性および用量調整 chemotherapy hepatotoxicity and dose modification in patients with liver disease
- 3. 化学療法関連腎毒性および腎不全患者における用量調整 chemotherapy related nephrotoxicity and dose modification in patients with renal insufficiency
- 4. 小児癌患者の骨に関する問題 bone problems in childhood cancer patients
- 5. 心臓移植における免疫抑制療法の導入および維持 induction and maintenance of immunosuppressive therapy in cardiac transplantation
English Journal
- Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.
- Zhang D, Ochi N, Takigawa N, Tanimoto Y, Chen Y, Ichihara E, Hotta K, Tabata M, Tanimoto M, Kiura K.SourceDepartment of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
- Cancer letters.Cancer Lett.2011 Oct 28;309(2):228-35. Epub 2011 Jun 24.
- Pemetrexed (PEM), a multitargeted antifolate with manageable toxicity, is active against non-squamous non-small cell lung cancer; however, most patients eventually acquire resistance to PEM. To elucidate the resistant mechanism, we established PEM-resistant lung adenocarcinoma cell lines. Two parent
- PMID 21742432
- [Therapy-related acute leukemia: study of 23 pacients].
- Motllo C, Manuel Sancho J, Garcia O, Granada I, Milla F, Ribera JM.SourceServicio de Hematologia Clinica, ICO-Hospital Universitari Germans Trias i Pujol, Institut de Recerca contra la Leucemia Josep Carreras, Universitat Autonoma de Barcelona, Badalona, Barcelona, Espana.
- Medicina clinica.Med Clin (Barc).2011 Oct 15;137(10):449-52. Epub 2011 Jun 22.
- BACKGROUND AND OBJECTIVE: The growing use of antineoplastic treatments has led to an increase in the incidence of therapy-related leukemias (TRL). The objective was to describe the characteristics of TRL.PATIENTS AND METHODS: Twenty-three cases of TRL were registered. Chemotherapeutic agents used fo
- PMID 21696789
Related Links
- antimetabolite /an・ti・me・tab・o・lite/ (an″te-) (an″ti-m?-tab´o-l?t) a substance bearing a close structural resemblance to one required for normal physiological functioning, and exerting its effect by interfering with the utilization of the essential ...
Related Pictures
★リンクテーブル★
| リンク元 | 「抗悪性腫瘍性代謝拮抗剤」「抗悪性腫瘍性代謝拮抗薬」 |
| 関連記事 | 「antineoplastic」「antimetabolite」 |
「抗悪性腫瘍性代謝拮抗剤」
「抗悪性腫瘍性代謝拮抗薬」
「antineoplastic」
「antimetabolite」